Recent Updates
Recently added Catalysts
BLTE Positive Sentiment

Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results

Tuesday, November 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Belite Bio, Inc (NASDAQ: BLTE) has announced a webcast scheduled for November 12, 2024, at 4:30 p.m. Eastern Time. The event will focus on discussing the company's financial results for the third quarter ended September 30, 2024, as well as provide a business update. Interested parties can join the webinar through a specified link. A replay will be available for 90 days after the event.
Price reaction · baseline $69.71 (2024-11-04 close) · hit after-hours · clean, no other BLTE news in the window
day 0 close · peak
+0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is hosting a webcast to update investors on financial results.
  • The company is focused on addressing significant unmet medical needs in retinal diseases.
  • The finance results discussion indicates a proactive approach to investor relations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
6.1%
average across 7 past catalysts
Lead asset
Tinlarebant
Phase 3 · Geographic Atrophy

Full Press Release Details

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Tuesday, November 12, 2024, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the third quarter ended September 30, 2024.
Date: Tuesday, November 12, 2024
Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Webcast Link: https://wsw.com/webcast/cc/blte5/1423080
Webcast Link Instructions
You can join the live webcast by visiting the link above or the “Presentations & Events” section of the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events. A replay will be available for approximately 90 days after the event.
Media and Investor Relations Contact:

Frequently Asked Questions

When will Belite Bio host its webcast?

Belite Bio will host its webcast on November 12, 2024.

What time is the webcast scheduled for?

The webcast is scheduled for 4:30 p.m. Eastern Time.

Where can I find the webcast link?

The webcast link is available at https://wsw.com/webcast/cc/blte5/1423080.

How long will the webcast replay be available?

A replay of the webcast will be available for 90 days post-event.

Who can I contact for investor relations?

You can contact investor relations at belite@argotpartners.com.

ShareAdd on Google
Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio financial results retinal diseases Q3 2024
Last updated: Nov 5, 2024

Biotech snapshot

Lead asset
TinlarebantPhase 3
Geographic Atrophy →

Catalyst track record

+33%
best trade around BLTE's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for BLTE.

See every catalyst's timing & PoA →